D. Ngo

1.9k total citations
80 papers, 1.4k citations indexed

About

D. Ngo is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, D. Ngo has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Physiology. Recurrent topics in D. Ngo's work include Chemotherapy-induced cardiotoxicity and mitigation (18 papers), Nitric Oxide and Endothelin Effects (9 papers) and Cardiovascular Function and Risk Factors (8 papers). D. Ngo is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (18 papers), Nitric Oxide and Endothelin Effects (9 papers) and Cardiovascular Function and Risk Factors (8 papers). D. Ngo collaborates with scholars based in Australia, United States and United Kingdom. D. Ngo's co-authors include Aaron L. Sverdlov, John D. Horowitz, Yuliy Y. Chirkov, Wai Ping Alicia Chan, John J. McNeil, Tamila Heresztyn, Nathan Procter, Noyan Gokce, Shakun Karki and Melissa G. Farb and has published in prestigious journals such as Circulation, PLoS ONE and Scientific Reports.

In The Last Decade

D. Ngo

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Ngo Australia 22 647 304 281 197 191 80 1.4k
Yoichiro Otaki Japan 23 665 1.0× 311 1.0× 311 1.1× 230 1.2× 101 0.5× 93 1.7k
Yusuke Nakagawa Japan 21 573 0.9× 261 0.9× 501 1.8× 117 0.6× 130 0.7× 86 1.7k
Colin Cunnington United Kingdom 21 845 1.3× 437 1.4× 208 0.7× 160 0.8× 88 0.5× 46 1.6k
Aaron L. Sverdlov Australia 26 1.0k 1.6× 465 1.5× 411 1.5× 200 1.0× 227 1.2× 103 2.0k
Riyaz S. Patel United States 16 547 0.8× 149 0.5× 320 1.1× 103 0.5× 266 1.4× 29 1.4k
Takaatsu Kamada Japan 16 579 0.9× 232 0.8× 216 0.8× 151 0.8× 125 0.7× 25 1.1k
Jan R. Ortlepp Germany 24 620 1.0× 171 0.6× 178 0.6× 313 1.6× 230 1.2× 55 1.4k
Anders Jorsal Denmark 24 641 1.0× 410 1.3× 473 1.7× 173 0.9× 142 0.7× 39 1.9k
Ninian N. Lang United Kingdom 26 922 1.4× 287 0.9× 441 1.6× 126 0.6× 185 1.0× 87 2.1k
Yasuhiro Izumiya Japan 20 722 1.1× 219 0.7× 187 0.7× 114 0.6× 74 0.4× 82 1.4k

Countries citing papers authored by D. Ngo

Since Specialization
Citations

This map shows the geographic impact of D. Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ngo more than expected).

Fields of papers citing papers by D. Ngo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ngo. The network helps show where D. Ngo may publish in the future.

Co-authorship network of co-authors of D. Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of D. Ngo. A scholar is included among the top collaborators of D. Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Ngo. D. Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sverdlov, Aaron L., et al.. (2025). Cardiometabolic perturbations arising from treatment with novel anticancer therapies. Trends in Cardiovascular Medicine.
2.
Noman, Nasimul, et al.. (2025). Factors influencing the adoption of Internet of Medical Things for remote patient monitoring: A systematic literature review. Computers in Biology and Medicine. 192(Pt B). 110142–110142.
3.
Yu, Jie, et al.. (2025). Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding. Journal of Thrombosis and Thrombolysis. 59(2). 393–410. 1 indexed citations
4.
5.
Croft, Amanda, Dongqing Chen, Tatt Jhong Haw, et al.. (2024). Sex-based differences in short- and longer-term diet-induced metabolic heart disease. American Journal of Physiology-Heart and Circulatory Physiology. 326(5). H1219–H1251. 2 indexed citations
6.
Haw, Tatt Jhong, et al.. (2024). Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic?. Heart Lung and Circulation. 33(5). 747–752. 7 indexed citations
7.
Ngo, D., et al.. (2024). Navigating cardiotoxicity risk in cancer therapy: the importance of the HFA-ICOS score. European Heart Journal. 46(3). 285–287. 2 indexed citations
9.
Chu, Matthew, Dongqing Chen, Amanda Croft, et al.. (2023). Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function. Journal of Cardiovascular Development and Disease. 10(7). 274–274. 4 indexed citations
10.
Ngo, D., et al.. (2022). Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology. Current Oncology Reports. 24(12). 1751–1763. 13 indexed citations
11.
Al-Omary, M., Tazeen Majeed, D. Ngo, et al.. (2021). Heart failure outcomes in Aboriginal and Torres Strait Islander peoples in the Hunter New England region of New South Wales. International Journal of Cardiology. 334. 65–71. 4 indexed citations
12.
Cehic, D., et al.. (2021). The Importance of Primary Care in Cardio-Oncology. Current Treatment Options in Oncology. 22(12). 107–107. 7 indexed citations
13.
Ngo, D., Leonard Kritharides, Janette L. Vardy, et al.. (2020). Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab. Journal of Clinical Medicine. 9(8). 2664–2664. 20 indexed citations
14.
Kirana, Chandra, Eric Smith, D. Ngo, et al.. (2020). High Preoperative Levels of Circulating SFRP5 Predict Better Prognosis in Colorectal Cancer Patients. Future Oncology. 16(31). 2499–2509. 9 indexed citations
15.
Ngo, D., et al.. (2020). Prolonged Suppression of the Anti-Oxidant/Anti-Inflammatory Effects of BNP Post-Takotsubo Syndrome. ESC Heart Failure. 7(5). 2250–2257. 5 indexed citations
16.
Ngo, D., Cher‐Rin Chong, Nathan Procter, et al.. (2015). Suppression of Neutrophil Superoxide Generation by BNP is Attenuated in Acute Heart Failure: A Case for ‘BNP Resistance’. European Journal of Heart Failure. 17(5). 475–483. 10 indexed citations
17.
Chong, Cher‐Rin, et al.. (2014). Reversal of Hyperglycemia: Effects on Nitric Oxide Signaling. The American Journal of Medicine. 128(4). 427–430. 6 indexed citations
18.
Procter, Nathan, Jocasta Ball, Irene Stafford, et al.. (2014). Impaired platelet nitric oxide response in patients with new onset atrial fibrillation. International Journal of Cardiology. 179. 160–165. 16 indexed citations
19.
Ngo, D., Nigel E Drury, Duilio Pagano, Michael Frenneaux, & John D. Horowitz. (2011). Abstract 14461: How Does Perhexiline Modulate Myocardial Energetics and Ameliorate Redox Stress?. Circulation. 124. 7 indexed citations
20.
Ngo, D., Irene Stafford, Darren J. Kelly, et al.. (2008). Vitamin D2 supplementation induces the development of aortic stenosis in rabbits: Interactions with endothelial function and thioredoxin-interacting protein. European Journal of Pharmacology. 590(1-3). 290–296. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026